Research / BFI Working Paper, Development Innovation LabJun 05, 2022

Can Education be Standardized? Evidence from Kenya

Guthrie Gray-Lobe, Anthony Keats, Michael Kremer, Isaac Mbiti, Owen Ozier

We examine the impact of enrolling in schools that employ a highly-standardized approach to education, using random variation from a large nationwide scholarship program. Bridge International Academies not only delivers highly detailed lesson guides to teachers using tablet computers, it also standardizes systems for daily teacher monitoring and feedback, school construction, and financial management. At the time of the study, Bridge operated over 400 private schools serving more than 100,000 pupils. It hired teachers with less formal education and experience than public school teachers, paid them less, and had more working hours per week. Enrolling at Bridge for two years increased test scores by 0.89 additional equivalent years of schooling (EYS) for primary school pupils and by 1.48 EYS for pre-primary pupils. These effects are in the 99th percentile of effects found for at-scale programs studied in a recent survey. Enrolling at Bridge reduced both dispersion in test scores and grade repetition. Test score results do not seem to be driven by rote memorization or by income effects of the scholarship.

More Research From These Scholars

BFI Working Paper, Development Innovation Lab Mar 30, 2022

Water Treatment and Child Mortality: A Meta-analysis and Cost-effectiveness Analysis

Michael Kremer, Stephen Luby, Ricardo Maertens, Brandon Tan, Witold Więcek
Topics:  Development Economics
Development Innovation Lab, Journal Article Feb 10, 2022

Testing fractional doses of COVID-19 vaccines

Witold Więcek, Amrita Ahuja, Esha Chaudhuri, Michael Kremer, Alexandre Simoes Gomes, Christopher M. Snyder, Alex Tabarrok, Brandon Joel Tan
Topics:  Development Economics
BFI Working Paper Dec 7, 2020

Designing Advance Market Commitments for New Vaccines

Michael Kremer, Jonathan D. Levin, Christopher M. Snyder
Topics:  Health care, COVID-19